# Contineum Therapeutics

**Website:** http://www.contineum-tx.com

Contineum Therapeutics (Nasdaq: CTNM) is a clinical-stage biopharmaceutical company pioneering novel, oral small molecule therapies for NI&I indications with significant unmet need. Contineum is advancing a pipeline of internally-developed programs with multiple drug candidates now in clinical trials. PIPE-791 is an LPA1 receptor antagonist in clinical development for idiopathic pulmonary fibrosis and chronic pain. PIPE-307 is a selective inhibitor of the M1 receptor in clinical development for relapsing-remitting multiple sclerosis and major depressive disorder.

## Open positions

Browse all open jobs at Contineum Therapeutics: [View jobs](https://jobs.workable.com/jobs.md?companyId=d30db7e2-a057-4a81-a5a4-ad3623379b9d)